These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4303861)

  • 21. PULMONARY TUBERCULOSIS.
    CHAVES AD
    Mod Treat; 1964 Mar; 1():330-59. PubMed ID: 14159591
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR
    Bull Int Union Tuberc; 1968 Dec; 41():175-7. PubMed ID: 4885379
    [No Abstract]   [Full Text] [Related]  

  • 23. [Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
    Bialik IB
    Antibiotiki; 1971 Feb; 16(2):184-8. PubMed ID: 4326728
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of the addition of the 3rd agent on the combined therapy with ethionamide and kanamycin in tuberculosis in the mice].
    Matsumiya T; Freerksen E; Rosenfeld M
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):30-4. PubMed ID: 4991617
    [No Abstract]   [Full Text] [Related]  

  • 25. [The course and results of treatment of pulmonary tuberculosis as a function of the dosage of Pyrazinamide].
    Malinowska B; Pawlak F
    Gruzlica; 1970; 38(6):531-5. PubMed ID: 4317029
    [No Abstract]   [Full Text] [Related]  

  • 26. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
    Ramakrishnan CV; Parthasarathy R; Sambamoorthy S; Somasundaram PR; Subbammal S
    Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
    Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
    Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
    [No Abstract]   [Full Text] [Related]  

  • 28. CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE.
    KASS I
    Tubercle; 1965 Jun; 46():166-77. PubMed ID: 14327964
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of drug failure cases.
    Dingley HB
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():76-89. PubMed ID: 4145683
    [No Abstract]   [Full Text] [Related]  

  • 31. Ethambutol in re-treatment of pulmonary tuberculosis.
    Am Rev Respir Dis; 1968 Nov; 98(5):825-36. PubMed ID: 4300827
    [No Abstract]   [Full Text] [Related]  

  • 32. Rifampin in original treatment of pulmonary tuberculosis. A United States Public Health Service cooperative therapy trial.
    Corpe R
    Bull Int Union Tuberc; 1972 Feb; 47():41-7. PubMed ID: 4562017
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the combination therapy of capreomycin. Ethionamide. Cycloserine with that of kanamycin. Ethionamide. Cycloserin in the retreatment of pulmonary tuberculosis.
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):1-13. PubMed ID: 4990959
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect and toxicity on the combined use of pyrazinamide, ethionamide and kanamycin in the retreatment of pulmonary tuberculosis (author's transl)].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(4):199-200. PubMed ID: 555425
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
    [No Abstract]   [Full Text] [Related]  

  • 36. Report on experiences with ethambutol.
    Böszörményi M
    Antibiot Chemother; 1970; 16():292-3. PubMed ID: 5535615
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bacterial resistance tests against secondary antitubercular agents--reliability of the routine methods].
    Tsukamura M
    Iryo; 1966 Mar; 20(3):241-50. PubMed ID: 5964831
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of pulmonary tuberculosis in patients resistant to major drugs with second line drugs].
    Ibarra JP; Piñeyro J; Trenchi A; Tarallo NH; Lanne de Farriols ME; Cuñarro de Gimeno G; Fernández Latorre I
    Hoja Tisiol; 1967; 24(1):5-88. PubMed ID: 4308762
    [No Abstract]   [Full Text] [Related]  

  • 39. [Various biological tests on several groups of subjects with tuberculosis subjected respectively to monotherapy with isoniazid, viomycin, pyrazinamide, cycloserine, ethioniamide and kanamycin].
    DE SIMONI G; CATTANEO C
    Ann Ist Carlo Forlanini; 1962; 22():326-65. PubMed ID: 14026068
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.